Total Funding
55
71
Total FundingGrant raised
Growth Score 55 in past quarter
-2 pts
Heat Score 71 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
107806
Harm Reduction Therapeutics is a nonprofit pharmaceutical company advancing harm reduction therapies to promote public health.
- Judy Ashworth: Chief Medical Officer
Michael Hufford: Co-Founder and CEOPast Role: eNicotine.com, CMO & Co-Founder
